title: American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw - 2009 update.
authors: Division of Oral and Maxillofacial Surgery, Stony Brook School of Dental Medicine, Attending, Long Island Jewish Medical Center, New Hyde Park, NY, USA.
authors: Salvatore L
authors: SL
authors: Ruggiero
authors: Thomas B
authors: TB
authors: Dodson
authors: Leon A
authors: LA
authors: Assael
authors: Regina
authors: R
authors: Landesberg
authors: Robert E
authors: RE
authors: Marx
authors: Bhoomi
authors: B
authors: Mehrotra
mesh_terms: D000284:Administration, Oral; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002985:Clinical Protocols; D003657:Decision Making; D003937:Diagnosis, Differential; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007275:Injections, Intravenous; D007571:Jaw Diseases / Q000139:chemically induced* / Q000517:prevention & control; D009369:Neoplasms / Q000188:drug therapy; D019647:Oral Surgical Procedures; D010020:Osteonecrosis / Q000139:chemically induced* / Q000517:prevention & control; D011788:Quality of Life; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates